Dr Colin Wilde is lead scientist in the Company's cell-based assay programme and its cell-biological services to the pharmaceutical and biotechnology industries. He trained as a biochemist, has published >100 research papers in the field of biochemistry/cell biology, and is author of seven patents or patent applications in related fields. He was formerly Managing Director of Hannah InterActions Ltd, and was co-founder of AvantiCell Science in 2006. Colin has held a number of positions in European research consortia, and is Visiting Professor in the University degli Studi di Milano, Italy.

E-mail this page to a Colleague